Rivas SL

Language: Spanish
References: 12
Page: 37-43
PDF size: 407.15 Kb.

ABSTRACT

Cervical cancer is one of the main health problems around the world, especially in developing countries. Human papillomavirus is necessary for the development of cervical cancer, producing the precancerous lesions that can be detected by screening. With the introduction of screening programmes using cytology, developed countries were able to substantially reduce the incidence and mortality from this disease, but not the developing countries, where the screening programmes have faced important limitations. Despite of the achievements made with the cytology, it has significant restrictions that have motivated the investigation of new forms of screening that are already being used primarily in developed countries. Based on the experience of countries with more economic resources, measures for establishing successful programmes in the regions most affected by the disease should be taken.

REFERENCES

1. Arrossi, S. y otros. Incidence and mortality of cervical cancer in Latin America. Salud Pública de México 2003, 45 (S3), S306-S313.

2. Davey, E. et al. Effect of study design and quality of unsatisfactory rates, cytology classifications, and accuracy in liquid-based versus conventional cervical cytology: a systematic review. Lancet 2006; 367 (9505): 122-32

3. Denny, L. et al. Screening for cervical cancer in developing countries. Vaccine 2006; 24 (Suppl 3): 71-77.

4. Herrero et al. New approaches to cervical cancer screening in Latin America and the Caribbean. Vaccine 2008; 26 (Suppl 11): L49-58.

5. International Agency for Research on Cancer (IARC). World Cancer report. Francia. 2003; 167.

6. Kitchener, H. y otros. Achievements and limitations of cervical cytology screening. Vaccine 2006, 24 (S3), S63-S70.

7. Muñoz N, et al. Recommendations for cervical cancer prevention in Latin America and the Caribbean. Vaccine 2008; 26 (Suppl 11): L96-L107.

8. Murrillo R, et al. Cervical cancer screening programs in Latin America and the Caribbean. Vaccine 2008; 26 (Suppl 11): L37-48.

9. Sankaranarayanan, R. y otros. A critical assessment of screening methods for cervical neoplasia. International Journal of Gynecology and Obstetrics 2005, 89 (S2), S4-S12.

10. Sankanaranayanan R et al. Effect of visual screening on cervical cancer incidente and mortality in Tamil Nadu, India: a cluster randomized trial. Lancet 2007; 370 (9585): 398-406.

11. Schiffman, M. y Castle, P. Human papillomavirus: Epidemiology and Public Health. Archives of Pathology and Laboratory Medicine 2003, 127, 930-934.

12. Schiffman, M. y otros. Human papillomavirus and cervical cancer. The Lancet 2007, 370 (9590), 890-907.